X-Chem Acquires Glamorous AI — Immediately Creating a Leader in DEL-Powered AI Solutions
Combination Accelerates Outcomes in Early Drug Discovery WALTHAM, Mass.; Oct. 28, 2021 – X-Chem, the pioneer of DNA-encoded library (DEL)...
top of page
Search
- Jun 30, 2021
- 1 min
Glamorous AI presents at BioTrinity
We participated in BioTrinity 2021. This is the first in-person meeting we are attending this year, we are very much looking forward for...
- Apr 8, 2021
- 2 min
London-based GlamorousAI secures £440k grant funding from Innovate UK
London-based GlamorousAI Secures Grant From Innovate UK to Fund a £440k Project toward Development of New Treatments For Glioblastoma...
- Mar 23, 2021
- 1 min
Glamorous AI selected for International Trade’s Digital Health Campaign – ‘The First 100 Playbook’
Glamorous AI has been chosen to be a part of the DIT ‘First 100’; a list of innovative and emerging UK digital health-tech companies. The...
- Nov 7, 2020
- 1 min
Our CEO to join Novartis UK CSO in a panel discussion about diversity
On the 11th of November, the PM Society is organising a panel discussion around diversity and inclusion in Pharma and biotech. The panel...
- Nov 6, 2020
- 1 min
Our CEO is live today giving a keynote at Pharma R&D summit
Our CEO, Noor Shaker, is giving a keynote at Pharma R&D Informatics, Medicinal Chemistry and Cannabinoids Summit. The talk will cover...
- Nov 3, 2020
- 1 min
Glamorous AI participates in BioEurope 2020 Digital
Over the last week of October, we participated in BioEurope 2020. Although the event went digital this year, we really enjoyed a...
bottom of page